Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)
China flag China · Delayed Price · Currency is CNY
23.68
-0.77 (-3.15%)
Sep 10, 2026, 3:04 PM CST

SHE:300683 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
197.83648.33419.15510.22748.48184.05
Short-Term Investments
-2.234.560.3142.75491.39
Trading Asset Securities
196.94170.63449.69578.71144.04514.4
Cash & Short-Term Investments
394.77821.19873.41,0891,0351,190
Cash Growth
-46.55%-5.98%-19.81%5.21%-12.99%18.99%
Accounts Receivable
291.64298.58300.78254.58233.21264.48
Other Receivables
3.610.1100-3.18
Receivables
295.26298.69300.78254.58233.21270.15
Inventory
84.5782.94108.98117.41120.1871.65
Other Current Assets
456.3927.0523.1826.9855.4750.88
Total Current Assets
1,2311,2301,3061,4881,4441,583
Property, Plant & Equipment
637.61658.14729.69734.56654.23519.63
Long-Term Investments
40.1442.8516.5827.0888.8965.29
Goodwill
178.59178.59263.59263.59302.15316.17
Other Intangible Assets
216.69229.09253.44276.8890.3790
Long-Term Deferred Tax Assets
127.04120.52119.94109.4780.5971.64
Long-Term Deferred Charges
3234.5134.4931.962.622.39
Other Long-Term Assets
8.282.97212.5739.5143.8749.87
Total Assets
2,4712,5772,9372,9712,7072,698

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
34.6733.1364.3552.0858.0551.72
Accrued Expenses
13.046379.1159.8646.5146.42
Short-Term Debt
7.067.067.227.3230.0333.04
Current Portion of Long-Term Debt
44.2421.3714.8314.667.313.21
Current Portion of Leases
-0.935.124.80.71.87
Current Income Taxes Payable
5.182.173.872.842.464.52
Current Unearned Revenue
47.0253.7777.5411697.9966.38
Other Current Liabilities
130.83127.41111.2188.5841.6842.09
Total Current Liabilities
282.04308.85363.26346.15284.73249.25
Long-Term Debt
--11.5226.3240.9248.17
Long-Term Leases
3.393.95.3610.42.593.64
Long-Term Unearned Revenue
85.4183.0484.2530.4727.922.59
Long-Term Deferred Tax Liabilities
10.4611.3514.7416.4813.117.25
Other Long-Term Liabilities
--45.9245.922.4523.56
Total Liabilities
381.3407.14525.05475.73371.7354.46

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
130.89130.89130.89130.89122.1122.1
Additional Paid-In Capital
1,8371,8371,8371,8371,5571,557
Retained Earnings
114192.71423.98510.34631.16645.19
Total Common Equity
2,0822,1612,3922,4782,3102,324
Minority Interest
7.698.8719.817.3724.7918.65
Shareholders' Equity
2,0902,1692,4122,4962,3352,343
Total Liabilities & Equity
2,4712,5772,9372,9712,7072,698

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
54.6933.2644.0563.581.5589.92
Net Cash (Debt)
340.08787.93829.351,026953.731,100
Net Cash Growth
-51.45%-4.99%-19.14%7.55%-13.29%10.72%
Net Cash Per Share
2.606.036.347.907.4810.34
Filing Date Shares Outstanding
134.32130.89130.89130.89122.1122.1
Total Common Shares Outstanding
134.32130.89130.89130.89122.1122.1
Working Capital
948.94921.02943.071,1421,1591,333
Book Value Per Share
15.5016.5118.2718.9318.9219.04
Tangible Book Value
1,6871,7531,8751,9381,9181,918
Tangible Book Value Per Share
12.5613.3914.3214.8015.7115.71
Buildings
-503.22500.14500.38398.72350.14
Machinery
-521.43528.75480.61339.05291.83
Construction In Progress
-7.3611.022.99120.9934.27